Position in BIOA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$315,781
New position
Shares Held
18,055
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 83.40072002215453.ToString("F0")%
Shared 16.59927997784547.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $189,500,319 across 12 Drug Manufacturers - Specialty & Generic names. BIOA ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
435,397 | $51,468,277 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
1,365,932 | $45,171,370 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
598,026 | $35,445,000 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
438,002 | $21,089,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
101,953 | $13,431,287 | |
| 6 | HLN |
Haleon plc
|
795,403 | $7,961,983 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
433,385 | $6,002,382 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
142,029 | $4,329,043 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $315,781 | 18,055 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||